{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T15:48:48Z","timestamp":1785944928145,"version":"3.56.0"},"reference-count":37,"publisher":"BMJ","issue":"12","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Archives of Disease in Childhood"],"published-print":{"date-parts":[[2014,12,1]]},"DOI":"10.1136\/archdischild-2013-304741","type":"journal-article","created":{"date-parts":[[2014,5,2]],"date-time":"2014-05-02T04:19:45Z","timestamp":1399004385000},"page":"1078-1082","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":66,"title":["Toxic shock syndrome surveillance in UK children"],"prefix":"10.1136","volume":"99","author":[{"given":"S.","family":"Adalat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. J.","family":"Hackett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. E.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"In association with the British Paediatric Surveillance Unit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2014,5,1]]},"reference":[{"key":"key-10.1136\/archdischild-2013-304741-1","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S1473-3099(02)00222-0","article-title":"Superantigens: microbial agents that corrupt immunity","volume":"2","author":"Llewelyn","year":"2002","journal-title":"Lancet Infect Dis"},{"issue":"(Suppl 1)","key":"key-10.1136\/archdischild-2013-304741-2","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.1093\/clinids\/11.Supplement_1.S90","article-title":"Distribution and expression of toxic shock syndrome toxin 1 gene among Staphylococcus aureus isolates of toxic shock syndrome and non-toxic shock syndrome origin","volume":"11","author":"Bonventre","year":"1989","journal-title":"Rev Infect Dis"},{"key":"key-10.1136\/archdischild-2013-304741-3","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1038\/nm1202-800","article-title":"An immunogenetic and molecular basis for differences in outcomes of invasive group A streptococcal infections","volume":"8","author":"Kotb","year":"2002","journal-title":"Nat Med"},{"issue":"(Suppl 1)","key":"key-10.1136\/archdischild-2013-304741-4","first-page":"5","article-title":"Toxic shock syndrome in Britain\u2014epidemiology and microbiology","volume":"61","author":"de Saxe","year":"1985","journal-title":"Postgrad Med J"},{"key":"key-10.1136\/archdischild-2013-304741-5","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1086\/515012","article-title":"Epidemiological and clinical aspects of invasive group A streptococcal infections and the streptococcal toxic shock syndrome","volume":"27","author":"Eriksson","year":"1998","journal-title":"Clin Infect Dis"},{"key":"key-10.1136\/archdischild-2013-304741-6","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1136\/adc.60.6.563","article-title":"Toxic shock syndrome","volume":"60","author":"Buchdahl","year":"1985","journal-title":"Arch Dis Child"},{"key":"key-10.1136\/archdischild-2013-304741-7","doi-asserted-by":"crossref","first-page":"3399","DOI":"10.1001\/jama.1984.03350240045037","article-title":"Corticosteroid therapy for patients with toxic shock syndrome","volume":"252","author":"Todd","year":"1984","journal-title":"JAMA"},{"key":"key-10.1136\/archdischild-2013-304741-8","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1086\/376630","article-title":"Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial","volume":"37","author":"Darenberg","year":"2003","journal-title":"Clin Infect Dis"},{"key":"key-10.1136\/archdischild-2013-304741-9","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1086\/515199","article-title":"Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome\u2014a comparative observational study. The Canadian Streptococcal Study Group","volume":"28","author":"Kaul","year":"1999","journal-title":"Clin Infect Dis"},{"key":"key-10.1136\/archdischild-2013-304741-10","doi-asserted-by":"crossref","first-page":"ep97","DOI":"10.1136\/adc.2006.101030","article-title":"Toxic shock syndrome in burns: diagnosis and management","volume":"92","author":"Young","year":"2007","journal-title":"Arch Dis Child Educ Pract Ed"},{"key":"key-10.1136\/archdischild-2013-304741-11","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1093\/pubmed\/fdr058","article-title":"Surveillance of rare diseases: a public health evaluation of the British Paediatric Surveillance Unit","volume":"34","author":"Knowles","year":"2012","journal-title":"J Public Health (Oxf)"},{"issue":"(RR-10)","key":"key-10.1136\/archdischild-2013-304741-12","first-page":"1","article-title":"Case definitions for infectious conditions under public health surveillance. Centers for Disease Control and Prevention","volume":"46","year":"1997","journal-title":"MMWR Recomm Rep"},{"key":"key-10.1136\/archdischild-2013-304741-13","doi-asserted-by":"crossref","first-page":"807","DOI":"10.3201\/eid0506.990611","article-title":"Toxic shock syndrome in the United States: surveillance update, 1979 1996","volume":"5","author":"Hajjeh","year":"1999","journal-title":"Emerg Infect Dis"},{"key":"key-10.1136\/archdischild-2013-304741-14","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1001\/jama.1993.03500030088038","article-title":"Defining the group A streptococcal toxic shock syndrome. Rationale and consensus definition","volume":"269","author":"The Working Group on Severe Streptococcal Infections","year":"1993","journal-title":"JAMA"},{"key":"key-10.1136\/archdischild-2013-304741-15","unstructured":"http:\/\/www.ons.gov.uk\/ons\/datasets-and-tables\/index.html & http:\/\/www.cso.ie\/en\/statistics\/population\/"},{"key":"key-10.1136\/archdischild-2013-304741-16","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0305-4179(03)00047-0","article-title":"Bacterial toxicosis\/toxic shock syndrome as a contributor to morbidity in children with burns injuries","volume":"29","author":"Brown","year":"2003","journal-title":"Burns"},{"key":"key-10.1136\/archdischild-2013-304741-17","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3201\/eid1402.070888","article-title":"Severe Streptococcus pyogenes infections, United Kingdom, 2003\u20132004","volume":"14","author":"Lamagni","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"key-10.1136\/archdischild-2013-304741-18","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2165\/00148581-200507010-00002","article-title":"Toxic shock syndrome in children: epidemiology, pathogenesis, and management","volume":"7","author":"Chuang","year":"2005","journal-title":"Paediatr Drugs"},{"issue":"(Suppl 1)","key":"key-10.1136\/archdischild-2013-304741-19","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1093\/clinids\/11.Supplement_1.S28","article-title":"Active surveillance for toxic shock syndrome in the United States, 1986","volume":"11","author":"Gaventa","year":"1989","journal-title":"Rev Infect Dis"},{"key":"key-10.1136\/archdischild-2013-304741-20","first-page":"ii-92","article-title":"Summary of notifiable diseases, United States, 1998","volume":"47","author":"Centers for Disease Control and Prevention","year":"1999","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.1136\/archdischild-2013-304741-21","doi-asserted-by":"crossref","first-page":"19785","DOI":"10.2807\/ese.16.05.19785-en","article-title":"Increase in invasive Streptococcus pyogenes and Streptococcus pneumoniae infections in England, December 2010 to January 2011","volume":"16","author":"Zakikhany","year":"2011","journal-title":"Euro Surveill"},{"key":"key-10.1136\/archdischild-2013-304741-22","doi-asserted-by":"crossref","first-page":"19110","DOI":"10.2807\/ese.14.05.19110-en","article-title":"Increase in invasive group A streptococcal infections in England, Wales and Northern Ireland, 2008\u20139","volume":"14","author":"Lamagni","year":"2009","journal-title":"Euro Surveill"},{"key":"key-10.1136\/archdischild-2013-304741-23","unstructured":"http:\/\/www.hpa.org.uk\/hpr\/archives\/2013\/news1713.htm#igas"},{"key":"key-10.1136\/archdischild-2013-304741-24","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0305-4179(99)00142-4","article-title":"A survey into toxic shock syndrome (TSS) in UK burns units","volume":"26","author":"Edwards-Jones","year":"2000","journal-title":"Burns"},{"key":"key-10.1136\/archdischild-2013-304741-25","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1086\/428614","article-title":"Varicella-associated invasive group A streptococcal disease in Alberta, Canada\u20132000\u20132002","volume":"40","author":"Tyrrell","year":"2005","journal-title":"Clin Infect Dis"},{"key":"key-10.1136\/archdischild-2013-304741-26","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1001\/jama.1987.03390080043027","article-title":"Toxic shock syndrome. A newly recognized complication of influenza and influenza like illness","volume":"257","author":"MacDonald","year":"1987","journal-title":"JAMA"},{"key":"key-10.1136\/archdischild-2013-304741-27","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/0305-4179(85)90117-2","article-title":"The toxic shock syndrome in burned children","volume":"11","author":"Frame","year":"1985","journal-title":"Burns Incl Therm Inj"},{"key":"key-10.1136\/archdischild-2013-304741-28","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1128\/JCM.00422-08","article-title":"Epidemiology of severe Streptococcus pyogenes disease in Europe","volume":"46","author":"Lamagni","year":"2008","journal-title":"J Clin Microbiol"},{"key":"key-10.1136\/archdischild-2013-304741-29","doi-asserted-by":"crossref","first-page":"E60","DOI":"10.1542\/peds.105.5.e60","article-title":"Invasive group A streptococcal disease in children and association with varicella-zoster virus infection. Ontario Group A Streptococcal Study Group","volume":"105","author":"Laupland","year":"2000","journal-title":"Pediatrics"},{"key":"key-10.1136\/archdischild-2013-304741-30","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00006454-199401000-00011","article-title":"Apparent lower rates of streptococcal toxic shock syndrome and lower mortality in children with invasive group A streptococcal infections compared with adults","volume":"13","author":"Davies","year":"1994","journal-title":"Pediatr Infect Dis J"},{"key":"key-10.1136\/archdischild-2013-304741-31","first-page":"201","article-title":"Toxic-shock syndrome, United States, 1970\u20131982","volume":"31","author":"Centers for Disease Control (CDC)","year":"1982","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"(1 Pt 1)","key":"key-10.1136\/archdischild-2013-304741-32","first-page":"136","article-title":"Committee on Infectious Diseases. Severe invasive group A streptococcal infections: a subject review","volume":"101","author":"American Academy of Pediatrics","year":"1998","journal-title":"Pediatrics"},{"key":"key-10.1136\/archdischild-2013-304741-33","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/infdis\/158.1.23","article-title":"The Eagle effect revisited: efficacy of clindamycin, erythromycin, and penicillin in the treatment of streptococcal myositis","volume":"158","author":"Stevens","year":"1988","journal-title":"J Infect Dis"},{"key":"key-10.1136\/archdischild-2013-304741-34","first-page":"660","article-title":"Toxic shock syndrome","volume-title":"Red Book: 2006 Report of the Committee on Infectious Diseases","author":"American Academy of Pediatrics","year":"2006","edition":"27"},{"key":"key-10.1136\/archdischild-2013-304741-35","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/jac\/dkl173","article-title":"Human intravenous immunoglobulin for experimental streptococcal toxic shock: bacterial clearance and modulation of inflammation","volume":"58","author":"Sriskandan","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"key-10.1136\/archdischild-2013-304741-36","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1592\/phco.19.13.1094.31589","article-title":"Intravenous immunoglobulin as adjunctive treatment for streptococcal toxic shock syndrome associated with necrotizing fasciitis: case report and review","volume":"19","author":"Cawley","year":"1999","journal-title":"Pharmacotherapy"},{"key":"key-10.1136\/archdischild-2013-304741-37","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1086\/606048","article-title":"Intravenous immunoglobulin in children with streptococcal toxic shock syndrome","volume":"49","author":"Shah","year":"2009","journal-title":"Clin Infect Dis"}],"container-title":["Archives of Disease in Childhood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/archdischild-2013-304741","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T17:40:01Z","timestamp":1648921201000},"score":1,"resource":{"primary":{"URL":"https:\/\/adc.bmj.com\/lookup\/doi\/10.1136\/archdischild-2013-304741"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,1]]},"references-count":37,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2014,11,13]]},"published-print":{"date-parts":[[2014,12,1]]}},"URL":"https:\/\/doi.org\/10.1136\/archdischild-2013-304741","relation":{},"ISSN":["0003-9888","1468-2044"],"issn-type":[{"value":"0003-9888","type":"print"},{"value":"1468-2044","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,1]]}}}